Funding Gaps Exposed for Rare Disease Patients in India

Original: RTI Flags Funding Gaps As Rare Disease Patients Hit Financial Limits

Ndtv•Apr 2, 20262 min

In a Nutshell

An RTI response reveals that 34 rare disease patients in India have exhausted the ₹50 lakh treatment cap under the National Policy for Rare Diseases, highlighting significant funding gaps. The report calls for urgent policy reforms to ensure sustainable financial support for lifelong treatments.

Key Points

0134 patients have exceeded the ₹50 lakh treatment cap for rare diseases.
02Only 350 out of 553 applicants received financial assistance, with 170 still pending.
03₹46.98 crore was allocated to AIIMS for rare disease treatment, but only ₹34 crore was disbursed.
04Concerns about unspent funds at treatment centers indicate administrative inefficiencies.
05Experts advocate for a policy overhaul to address funding limitations for lifelong therapies.

In-Article Ad

Full Summary

A recent Right to Information (RTI) response has highlighted critical funding gaps for rare disease patients in India, revealing that 34 patients have already exceeded the ₹50 lakh (roughly $60,000 USD) treatment cap established under the National Policy for Rare Diseases. Rare diseases, often genetic and requiring lifelong care, pose significant financial burdens on patients. The RTI data shows that the All India Institute of Medical Sciences (AIIMS) received approximately ₹46.98 crore over the past five years, but only ₹34 crore has been distributed to patients. Of 553 applications for financial assistance, only 350 have been approved, leaving 170 pending and 24 rejected. The report also indicates that ₹189 crore was allocated to 13 Centres of Excellence, yet many centers reported unspent funds, raising concerns about implementation. Experts are calling for urgent reforms to address these issues, particularly the inadequacy of the ₹50 lakh cap for lifelong therapies, emphasizing the need for a sustainable funding framework to ensure patients receive timely access to life-saving treatments.

Key Figures

₹50 lakh

Treatment cap for rare diseases

34

Patients who have exceeded the treatment cap

553

Total applications for financial assistance

₹46.98 crore

Total funds allocated to AIIMS for rare disease treatment

In-Article Ad

Why It Matters

The funding gaps and delays in financial assistance could jeopardize access to essential treatments for rare disease patients, affecting their health outcomes.

Who is affected

Patients with rare diseases and their families.

What to know

Advocacy for policy reforms to increase the treatment cap and streamline the application process for financial support.

FAQ

The treatment cap is ₹50 lakh (approximately $60,000 USD) under the National Policy for Rare Diseases.

Out of 553 applicants, only 350 patients have received financial assistance.

✦